Management of papillary thyroid microcarcinoma: Primum non nocere!

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages 1391-1393

  Pacini, Furio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; BRAF GENE; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE REGISTRY; DISTANT METASTASIS; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; ETHNICITY; GENE EXPRESSION PROFILING; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; ITALY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; ONCOGENE; PAPILLARY THYROID MICROCARCINOMA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; THYROID CARCINOMA; THYROID SURGERY; THYROIDECTOMY; TREND STUDY; UNITED STATES;

CARCINOMA; FEMALE; HUMANS; MALE; REGISTRIES; THYROID NEOPLASMS;

EID: 84876230867     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1634     Document Type: Review

References (15)

1. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787-803.
3. Malandrino P, Pellegriti G, Attard M, et al. Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries. J Clin Endocrinol Metab. 2013;98:1427-1434.
4. Yu XM, Wan Y, Sippel RS, Chen H. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg. 2011;254:653-660.
5. Buffet C, Golmard JL, Hoang C, et al. Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma. Eur J Endocrinol. 2012;167:267-275.
6. Pacini F. Thyroid microcarcinoma. Best Pract Res Clin Endocrinol Metab. 2012;26:381-389.
7. Sobin LH, Gospodarowicz MK, Wittekind C. UICC International Union Against Cancer, TNM Classification of Malignant Tumours. 7th ed. Oxford, UK: Wiley-Blackwell; 2010.
8. Tuttle RM, Tala H, Shah J, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the New American Thyroid Association staging system. Thyroid. 2010;20:1341-1349.
9. Castagna MG, Maino F, Cipri C, et al. Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients. Eur J Endocrinol. 2011;165:441-446.
10. Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367:705-715.
11. Elisei R, Viola D, Torregrossa L, et al. The BRAF(V600E) mutation isanindependent, poor prognostic factor for the out come of patients with low-risk intrathyroid papillary thyroid carcinoma: single institution results from a large cohort study. J Clin Endocrinol Metab. 2012;97:4390-4398.
12. Niemeier LA, Kuffner AH, Song C, et al. A combined molecularpathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer. 2011;118:2069-2077.
13. Lee ST, Kim SW, Ki CS, et al. Clinical implication of highly sensitive detection of the BRAF V600E mutationin fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area. J Clin Endocrinol Metab. 2012;97:2299-2306.
14. Wartofsky L. Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab. 2012;97:1169-1172.
15. Ito Y, Miyauchi A, Inoue H, et al. Anobservational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28-35.